Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 30, 2015 6:48 PM ET

Pharmaceuticals

Company Overview of NuPathe, Inc.

Company Overview

NuPathe Inc., a specialty pharmaceutical company, focuses on the development and commercialization of branded therapeutics for neurological and psychiatric disorders. The company’s lead product is Zecuity, which is a sumatriptan iontophoretic transdermal system used for the acute treatment of migraine with or without aura in adults. Its pipeline product candidates include NP201 for the continuous symptomatic treatment of Parkinson's disease; and NP202 for the long-term treatment of schizophrenia and bipolar disorder. The company develops its products using SmartRelief, a proprietary transdermal medication delivery technology based on iontophoresis, a non-invasive method of actively transport...

7 Great Valley Parkway

Suite 300

Malvern, PA 19355

United States

Founded in 2005

14 Employees

Phone:

610-232-0800

Fax:

610-232-0571

Key Executives for NuPathe, Inc.

Senior Vice President, General Counsel and Corporate Secretary
Age: 38
Chief Commercial Officer and Senior Vice President
Age: 46
Chief Scientific Officer and Vice President
Vice President of Communications & Investor Relations
Vice President of Development
Compensation as of Fiscal Year 2014.

NuPathe, Inc. Key Developments

NuPathe, Inc.(NasdaqGM:PATH) dropped from NASDAQ Composite Index

NuPathe, Inc. will be removed from the NASDAQ Composite Index.

NuPathe, Inc. Announces Amendments to its Certificate of Incorporation

NuPathe, Inc. announced that pursuant to the terms of the Merger Agreement, the company's certificate of incorporation was amended and restated in its entirety, effective as of the effective time.

NuPathe, Inc. Presents at The Goldman Sachs Technology and Internet Conference 2014, Feb-11-2014 09:00 AM

NuPathe, Inc. Presents at The Goldman Sachs Technology and Internet Conference 2014, Feb-11-2014 09:00 AM. Venue: The Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.

Similar Private Companies By Industry

Company Name Region
Coquí RadioPharmaceuticals, Corp. United States
MediNiche, Inc. United States
Boland Naturals, Inc. United States
NanoMedex Pharmaceuticals, Inc. United States
Roivant Sciences, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NuPathe, Inc., please visit www.nupathe.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.